Stay updated with breaking news from Tuberculosis Vaccine Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COVID-19 vaccine franchise focused on vaccine adaptation readiness ahead of the fall season and advancing next generation vaccine candidates and combinationsBioNTech and partner OncoC4 plan to start a
Investegate announcements from BioNTech SE, BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
Fourth quarter and full year revenues of €5.5 billion1 and €19.0 billion1, respectivelyFull year net income of €10.3 billion and fully diluted earnings per share of €39.63 ($46.872)Expect to authorize